Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diesel Exhaust and Glucocorticoid Resistance in Asthma
NCT03615742Phase 4Recruiting
- Sponsor
- University of British Columbia
- Start
- Dec 2018
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of budesonide in asthma (4 arms), sponsored by University of British Columbia. Primary endpoint: Change in DNA methylation, mRNA and protein expression attributable to diesel exhaust and inhaled corticosteroid at 6 hours. Started Dec 2018; status: recruiting.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03615742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03615742.